[On-Demand Webinar Now Streaming] Gene-Modified T Cell Therapy - Adoptive Cell Therapy with Gene Engineered T Cells -

I talked about the development status of gene-modified T cell therapy and the latest initiatives at Mie University. Dr. Tamaki's team has three key focuses in CAR cell therapy development: "strictly specific receptors (pMHC recognition)," "original activation constructs (targeting GITR)," and "next-generation cell adjustments (automated adjustment devices)." This is summarized with a detailed theoretical background, key equipment used, and actual measurement data.
You can find more here ⇒ https://event.on24.com/wcc/r/3338170/31426FFE70961897BB5A449BAC0D7C35?partnerref=ipros
Additionally, we are currently streaming webinars on cell culture environment analysis → https://www2.novabio.us/jp-biowebinar
Nova Biomedical Corporation
![[On-Demand Webinar Now Streaming]](https://image.mono.ipros.com/public/news/image/1/132/87730/IPROS28878586814574173471.jpeg?w=280&h=280)
Date and time | Always open |
---|---|
Entry fee | Free |
Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration
Related product
Related catalog(4)
![[Verification Material] The Importance of Analyzing Culture Medium Components in iPS Cell Cultivation](https://image.mono.ipros.com/public/catalog/image/01/38c/440458/IPROS56142213031488853103.jpeg?w=120&h=170)
